Nkarta Inc Stock price
Is Nkarta Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.
Key metrics
Nkarta Inc Stock Analysis
Analyst Opinions
13 Analysts have issued a Nkarta Inc forecast:
Analyst Opinions
13 Analysts have issued a Nkarta Inc forecast:
Don't miss a Thing! We will send you all news about Nkarta Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Nkarta Inc Stock News
Company Profile
Nkarta, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer. The company was founded by Dario Campana in 2005 and is headquartered in South San Francisco, CA.
| Head office | United States |
| CEO | Mr. Hastings |
| Employees | 108 |
| Founded | 2005 |
| Website | www.nkartatx.com |


